Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
![PumaBiotech on Twitter: "Ongoing support remains a challenge for HER2+ #breastcancer patients facing the risk of recurrence and progression. Our mission is to help oncologists support their patients. Learn more about what PumaBiotech on Twitter: "Ongoing support remains a challenge for HER2+ #breastcancer patients facing the risk of recurrence and progression. Our mission is to help oncologists support their patients. Learn more about what](https://pbs.twimg.com/media/E3Ry6u8WYAAkwPc.jpg)
PumaBiotech on Twitter: "Ongoing support remains a challenge for HER2+ #breastcancer patients facing the risk of recurrence and progression. Our mission is to help oncologists support their patients. Learn more about what
![PUG Procedure in ICU — CoapTech | The PUMA-G System | The World's First Ultrasound Gastrostomy Solution PUG Procedure in ICU — CoapTech | The PUMA-G System | The World's First Ultrasound Gastrostomy Solution](http://static1.squarespace.com/static/56fd7b11f8baf3caf1adfd9d/5c6683ea7817f71f33edf4c2/5c685b0f085229f28765a55d/1626195322564/Screen+Shot+2021-07-13+at+12.53.38+PM.png?format=1500w)